NCT00189748已完成2 期
An Extension Study of the Patients Enrolled in Acute Graft Versus Host Disease (GVHD) Prophylaxis Study (Protocol No. FJ-506E-BT01) to Assess Safety and Efficacy of GVHD Prophylaxis of a Tacrolimus New Oral Formulation (MR4).
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 试验地点
- 4
研究概览
简要总结
To assess safety and efficacy of the patients with MR4 therapy in GVHD prophylaxis study who are eligible for the administration after 100 days post transplant (up to 1 year)
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 20 Years 至 54 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patient had enrolled in GVHD prophylaxis study.
- •Patient had been fully informed.
排除标准
- •The patient had been not eligible for the administration after 100 days post transplant in the investigator's judgement.
研究者
研究点 (4)
Loading locations...
相似试验
已完成
不适用
Follow-Up Study of Patients Previously Treated With Pimecrolimus Tablets for Chronic Plaque-Type PsoriasisPsoriasisNCT00098189Novartis
已完成
不适用
Follow-Up Study of Patients Previously Treated With Pimecrolimus Tablets for Atopic DermatitisAtopic DermatitisNCT00098150Novartis66
进行中（未招募）
不适用
Long Term Follow-Up for Safety of AVR-RD-02Gaucher DiseaseNCT06488261John Bernat2
终止
2 期
An Extension Study of V203-AD Study to Evaluate the Safety, Tolerability, Immunogenicity, and Efficacy of UB-311Alzheimer's DiseaseNCT03531710United Neuroscience Ltd.34
已完成
4 期
Study on the Prognosis and Effect of Anti-diabetic Drugs on Type-2 Diabetes Mellitus With Coronary Artery DiseaseCoronary Artery DiseaseType 2 DiabetesNCT00513630Shanghai Jiao Tong University School of Medicine304